XML 59 R68.htm IDEA: XBRL DOCUMENT v2.4.0.8
Guarantor and Non-Guarantor Financial Statements (Details) (USD $)
In Millions, unless otherwise specified
3 Months Ended 3 Months Ended 3 Months Ended 3 Months Ended 3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Dec. 31, 2013
Mar. 31, 2014
Parent
Mar. 31, 2013
Parent
Dec. 31, 2013
Parent
Mar. 31, 2014
Guarantor Subsidiaries
Mar. 31, 2013
Guarantor Subsidiaries
Dec. 31, 2013
Guarantor Subsidiaries
Mar. 31, 2014
Non-Guarantor Subsidiaries
Mar. 31, 2013
Non-Guarantor Subsidiaries
Dec. 31, 2013
Non-Guarantor Subsidiaries
Mar. 31, 2014
Consolidating Adjustments
Mar. 31, 2013
Consolidating Adjustments
Dec. 31, 2013
Consolidating Adjustments
May 23, 2012
Senior Notes
Condensed Financial Statements [Line Items]                                
Principal amount of notes                               $ 225.0
Ownership interest by parent 100.00%                              
Current assets:                                
Cash and cash equivalents 185.6 248.0   5.0 5.0   174.3 241.6   6.3 1.4   0 0    
Short-term investments 104.5   129.5 0   0 104.5   129.5 0   0 0   0  
Receivables:                                
Trade, less allowance for doubtful receivables 123.5   119.8 0   0 119.5   117.7 4.0   2.1 0   0  
Intercompany receivables 0   0 32.2   0 25.4   0.1 0.7   0.2 (58.3)   (0.3)  
Other 11.7   13.4 0   0 5.9   5.3 5.8   8.1 0   0  
Inventories 203.1   214.4 0   0 198.0   208.6 5.8   6.4 (0.7)   (0.6)  
Prepaid expenses and other current assets 48.6   44.2 0.1   0.1 48.0   43.7 0.5   0.4 0   0  
Total current assets 677.0   690.8 37.3   5.1 675.6   662.6 23.1   24.0 (59.0)   (0.9)  
Investments in and advances to subsidiaries 0   0 1,466.5   1,437.9 26.9   26.5 0   0 (1,493.4)   (1,464.4)  
Property, plant, and equipment – net 436.7   429.3 0   0 421.6   414.0 15.1   15.3 0   0  
Long-term intercompany receivables 0   0 0   31.3 1.1   1.6 10.6   9.5 (11.7)   (42.4)  
Net asset of VEBAs 414.1   406.0 0   0 414.1   406.0 0   0 0   0  
Deferred tax assets — net 59.2   69.1 0   0 50.2   60.2 0   0 9.0   8.9  
Intangible assets – net 33.3   33.7 0   0 33.3   33.7 0   0 0   0  
Goodwill 37.2   37.2 0   0 37.2   37.2 0   0 0   0  
Other assets 108.5   104.8 90.1   86.2 18.3   18.5 0.1   0.1 0   0  
Total 1,766.0   1,770.9 1,593.9   1,560.5 1,678.3   1,660.3 48.9   48.9 (1,555.1)   (1,498.8)  
Current liabilities:                                
Accounts payable 72.3   62.9 0.4   1.1 66.6   56.3 5.3   5.5 0   0  
Intercompany payable 0   0 22.8   0 36.9   13.9 1.9   0.1 (61.6)   (14.0)  
Accrued salaries, wages, and related expenses 33.2   42.7 0   0 29.9   39.3 3.3   3.4 0   0  
Other accrued liabilities 37.1   44.8 10.1   3.5 25.8   39.9 1.2   1.4 0   0  
Short-term capital lease 0.2   0.2 0   0 0.2   0.2 0   0 0   0  
Total current liabilities 142.8   150.6 33.3   4.6 159.4   149.6 11.7   10.4 (61.6)   (14.0)  
Deferred tax liability 1.2   1.2 0   0 0   0 1.2   1.2 0   0  
Long-term intercompany payable 0   0 1.0   0 10.7   40.7 0   1.7 (11.7)   (42.4)  
Long-term liabilities 149.0   146.4 86.6   83.2 51.3   52.0 11.1   11.2 0   0  
Long-term debt 390.7   388.5 390.7   388.5 0   0 0   0 0   0  
Total liabilities 683.7   686.7 511.6   476.3 221.4   242.3 24.0   24.5 (73.3)   (56.4)  
Total stockholders’ equity 1,082.3   1,084.2 1,082.3   1,084.2 1,456.9   1,418.0 24.9   24.4 (1,481.8)   (1,442.4)  
Total 1,766.0   1,770.9 1,593.9   1,560.5 1,678.3   1,660.3 48.9   48.9 (1,555.1)   (1,498.8)  
CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME                                
Net sales 335.1 337.4   0 0   327.1 331.8   33.1 30.4   (25.1) (24.8)    
Cost of products sold:                                
Cost of products sold, excluding depreciation and amortization and other items 282.9 263.6   0 0   278.9 259.7   28.4 27.0   (24.4) (23.1)    
Unrealized (gains) losses on derivative instruments (2.0) 0.7   0 0   (2.0) 0.7   0 0   0 0    
Depreciation and amortization 7.4 7.0   0 0   7.1 6.7   0.3 0.3   0 0    
Selling, administrative, research and development, and general 20.3 21.7   1.0 0.4   16.6 20.4   3.3 2.4   (0.6) (1.5)    
Net periodic pension benefit income relating to VEBAs (5.6) (5.6)   0 0   (5.6) (5.6)   0 0   0 0    
Total selling, administrative, research and development, and general 14.7 16.1   1.0 0.4   11.0 14.8   3.3 2.4   (0.6) (1.5)    
Total costs and expenses 303.0 287.4   1.0 0.4   295.0 281.9   32.0 29.7   (25.0) (24.6)    
Operating (loss) income 32.1 50.0   (1.0) (0.4)   32.1 49.9   1.1 0.7   (0.1) (0.2)    
Other (expense) income:                                
Interest (expense) income (8.8) (9.3)   (9.3) (9.1)   0.4 (0.3)   0 0   0.1 0.1    
Other income, net 1.9 1.0   1.0 0.4   1.2 0.6   (0.2) 0.1   (0.1) (0.1)    
(Loss) income before income taxes 25.2 41.7   (9.3) (9.1)   33.7 50.2   0.9 0.8   (0.1) (0.2)    
Income tax (provision) benefit (9.4) (8.2)   0 0   (12.6) (19.0)   (0.3) 7.2   3.5 3.6    
Earnings in equity of subsidiaries 0 0   25.1 42.6   0.4 7.8   0 0   (25.5) (50.4)    
Net income 15.8 33.5   15.8 33.5   21.5 39.0   0.6 8.0   (22.1) (47.0)    
Comprehensive income 16.7 34.7   16.7 34.7   22.2 39.8   0.8 8.4   (23.0) (48.2)    
Cash flows from operating activities:                                
Net cash (used in) provided by operating activities 27.1 6.3   (11.0) (0.5)   35.8 5.4   2.3 1.4   0 0    
Cash flows from investing activities:                                
Capital expenditures (15.4) (9.3)   0 0   (15.4) (9.0)   0 (0.3)   0 0    
Purchase of available for sale securities 0 (85.6)     0     (85.6)     0     0    
Proceeds from disposition of available for sale securities 25.0 85.2   0 0   25.0 85.2   0 0   0 0    
Net cash provided by (used in) investing activities 9.6 (9.7)   0 0   9.6 (9.4)   0 (0.3)   0 0    
Cash flows from financing activities:                                
Excess tax benefit upon vesting of non-vested shares and dividend payment on unvested shares expected to vest 0.7 0.8   0 0   0.7 0.8   0 0   0 0    
Cancellation of shares to cover employees’ tax withholdings upon vesting of non-vested shares (2.2) (2.2)   (2.2) (2.2)   0 0   0 0   0 0    
Cash dividend paid to stockholders (6.4) (5.9)   (6.4) (5.9)   0 0   0 0   0 0    
Repurchase of common stock (12.7) (14.7)   (12.7) (14.7)   0 0   0 0   0 0    
Intercompany loan 0 0   32.3 23.3   (29.5) (21.2)   (2.8) (2.1)   0 0    
Net cash provided by (used in) financing activities (20.6) (22.0)   11.0 0.5   (28.8) (20.4)   (2.8) (2.1)   0 0    
Net increase (decrease) in cash and cash equivalents during the period 16.1 (25.4)   0 0   16.6 (24.4)   (0.5) (1.0)   0 0    
Cash and cash equivalents at beginning of period 169.5 273.4   5.0 5.0   157.7 266.0   6.8 2.4   0 0    
Cash and cash equivalents at end of period $ 185.6 $ 248.0   $ 5.0 $ 5.0   $ 174.3 $ 241.6   $ 6.3 $ 1.4   $ 0 $ 0